Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt

Molecular and Cellular Biology

Volumn 18, Issue 7, 1998, Pages 4131-4140

  Kontos, Christopher D ^a   Stauffer, Thomas P ^a   Yang, Wen Pin ^b   York, John D ^a   Huang, Liwen ^a,c   Blanar, Michael A ^b   Meyer, Tobias ^a   Peters, Kevin G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c Myriad Genetic Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE;

AMINO ACID SEQUENCE; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBUNIT; HUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0031834338     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.7.4131     Document Type: Article

References (73)

1. Ahmed, N. N., H. L. Grimes, A. Bellacosa, T. O. Chan, and P. N. Tsichlis. 1997. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc. Natl. Acad. Sci. USA 94:3627-3632.
2. Antonetti, D. A., P. Algenstaedt, and C. R. Kahn. 1996. Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain. Mol. Cell. Biol. 16:2195-2203.
3. Bae, Y. S., L. G. Cantley, C.-S. Chen, S.-R. Kim, K.-S. Kwon, and S. G. Rhee. 1998. Activation of phospholipase C-γ by phosphatidylinositol 3,4,5-triphosphate. J. Biol. Chem. 273:4465-4469.
4. Carpenter, C. L., and L. C. Cantley. 1996. Phosphoinositide kinases. Curr. Opin. Cell Biol. 8:153-158.
5. Chen, H.-C., P. A. Appeddu, H. Isoda, and J.-L. Guan. 1996. Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase. J. Biol. Chem. 271:26329-26334.
6. Crameri, A., E. A. Whitehorn, E. Tate, and P. C. Stemmer. 1996. Improved green fluorescent protein by molecular evolution using DNA shuffling. Nat. Biotechnol. 14:315-319.
7. Cunningham, S. A., M. N. Waxham, P. M. Arrate, and T. A. Brock. 1995. Interaction of the Fit-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase: mapping of a novel site involved in binding. J. Biol. Chem. 270:20254-20257.
8. Damen, J. E., R. L. Cutler, H. Jiao, T. Yi, and G. Krystal. 1995. Phosphorylation of tyrosine 503 in the erythropoietin receptor (EpR) is essential for binding the p85 subunit of phosphatidylinositol (PI) 3-kinase and for EpR-associated PI 3-kinase activity. J. Biol. Chem. 270:23402-23408.
9. Datta, S. R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M. E. Greenberg. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241.
10. Davis, S., T. H. Aldrich, P. F. Jones, A. Acheson, D. L. Compton, V. Jain, T. E. Ryan, J. Bruno, C. Radziejewski, P. C. Maisonpierre, and G. D. Yancopoulos. 1996. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161-1169.
11. del Peso, L., M. González-García, C. Page, R. Herrera, and G. Nuñez. 1997. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687-689.
12. Dubois, N. A., L. C. Kolpack, R. Wang, R. G. Azizkhan, and V. L. Bautch. 1991. Isolation and characterization of an established endothelial cell line from transgenic mouse hemangiomas. Exp. Cell Res. 196:302-313.
13. Dudek, H., S. R. Datta, T. F. Franke, M. J. Birnbaum, R. Yao, G. M. Cooper, R. S. Segal, D. R. Kaplan, and M. E. Greenberg. 1997. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275: 661-665.
14. Dumont, D. J., G.-H. Fong, G. Gradwohl, K. Alitalo, and M. L. Breitman. 1995. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev. Dyn. 203:80-92.
15. Dumont, D. J., G. Gradwohl, G.-H. Fong, M. C. Puri, M. Gertsenstein, A. Auerbach, and M. L. Breitman. 1994. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8:1897-1909.
16. Dumont, D. J., G. J. Gradwohl, G.-H. Fong, R. Auerbach, and M. L. Breitman. 1993. The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors. Oncogene 8:1293-1301.
17. Dumont, D. J., T. P. Yamaguchi, R. A. Conlon, J. Rossant, and M. L. Breitman. 1992. tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene 7:1471-1480.
18. Edgell, C. J. S., C. C. McDonald, and J. B. Graham. 1983. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. USA 80:3734-3737.
19. Estojak, J., R. Brent, and E. A. Golemis. 1995. Correlation of two-hybrid affinity data with in vitro measurements. Mol. Cell. Biol. 15:5820-5829.
20. Fantl, W. J., D. E. Johnson, and L. T. Williams. 1993. Signalling by receptor tyrosine kinases. Annu. Rev. Biochem. 62:453-481.
21. Folkman, J., and P. A. D'Amore. 1996. Blood vessel formation: what is its molecular basis? Cell 87:1153-1155.
22. Golemis, E. A., J. Gyuris, and R. Brent. 1995. Interaction trap/two-hybrid system to identify protein interactions, p. 13.14.1-13.14.17. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. John Wiley and Sons, Inc., New York, N.Y.
23. Gyuris, J., E. Golemis, H. Chertkov, and R. Brent. 1993. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 75:791-803.
24. Hanahan, D. 1997. Signaling vascular morphogenesis and maintenance. Science 277:48-50.
25. Hannon, G. J., D. Demetrick, and D. Beach. 1993. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev. 7:2378-2391.
26. Heim, R., A. B. Cubitt, and R. Tsien. 1995. Improved green fluorescence. Nature 373:663-664.
27. Hues, I. D., M. Otsu, S. Volinia, M. J. Fry, I. Gout, R. Dhand, G. Panayotou, F. Ruiz-Larrea, A. Thompson, N. F. Totty, J. J. Hsuan, S. A. Courtneidge, P. J. Parker, and M. D. Waterfield. 1992. Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell 70:419-429.
28. Holgado-Madruga, M., D. R. Emlet, D. K. Moscatello, A. K. Godwin, and A. J. Wong. 1996. A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379:560-564.
29. Holgado-Madruga, M., D. K. Moscatello, D. R. Emlet, R. Dieterich, and A. J. Wong. 1997. Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor. Proc. Natl. Acad. Sci. USA 94:12419-12424.
30. Holt, K. H., A. L. Olson, W. S. Moye-Rowley, and J. E. Pessin. 1994. Phosphatidylinositol 3-kinase activation is mediated by high-affinity interactions between distinct domains within the pi 10 and p85 subunits. Mol. Cell. Biol. 14:42-49.
31. Huang, L., C. W. Turck, P. Rao, and K. G. Peters. 1995. GRB2 and SH-PTP2: potentially important endothelial signaling molecules downstream of the TEK/TIE2 receptor tyrosine kinase. Oncogene 11:2097-2103.
32. Klippel, A., J. A. Escobedo, M. Hirano, and L. T. Williams. 1994. The interaction of small domains between the subunits of phosphatidylinositol 3-kinase determines enzyme activity. Mol. Cell. Biol. 14:2675-2685.
33. Klippel, A., W. M. Kavanaugh, D. Pot, and L. T. Williams. 1997. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol. Cell. Biol. 17:338-344.
34. Klippel, A., C. Reinhard, W. M. Kavanaugh, G. Appel, M.-A. Escobedo, and L. T. Williams. 1996. Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways. Mol. Cell. Biol. 16:4117-4127.
35. 34a. Kontos, C. D., L. Huang, W.-P. Yang, M. Blanar, and K. G. Peters. 1996. The p85 subunit of phosphatidylinositol 3′-kinase associates with the endothelium-specific receptor tyrosine kinase Tek. Circulation 94:1-405.
36. Kontos, C. D., L. Huang, and K. G. Peters. 1998. Unpublished data.
37. Kontos, C. D., and K. G. Peters. Unpublished data.
38. Korhonen, J., A. Polvi, J. Partanen, and K. Alitalo. 1994. The mouse tie receptor tyrosine kinase gene: expression during embryonic angiogenesis. Oncogene 9:395-403.
39. Kulik, G., A. Klippel, and M. J. Weber. 1997. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17:1595-1606.
40. Lin, P., P. Polverini, M. Dewhirst, S. Shan, P. S. Rao, and K. Peters. 1997. Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth. J. Clin. Invest. 100:2072-2078.
41. Liu, L., J. E. Damen, M. Ware, M. Hughes, and G. Krystal. 1997. SHIP, a new player in cytokine-induced signalling. Leukemia 11:181-184.
42. Liu, L., J. E. Damen, M. D. Ware, and G. Krystal. 1997. Interleukin-3 induces the association of the inositol 5-phosphatase SHIP with SHP2. J. Biol. Chem. 272:10998-11001.
43. Maisonpierre, P. C., M. Goldfarb, G. D. Yancopoulos, and G. Gao. 1993. Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family. Oncogene 8:1631-1637.
44. Maisonpierre, P. C., C. Suri, P. F. Jones, S. Bartunkova, S. J. Wiegand, C. Radziejewski, D. Compton, J. McClain, T. H. Aldrich, N. Papadopoulos, T. J. Daly, S. Davis, T. N. Sato, and G. D. Yancopoulos. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60.
45. Markowitz, D., S. Goff, and A. Bank. 1988. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62:11201124.
46. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-990.
47. Nguyen, L., M. Holgado-Madruga, C. Maroun, E. D. Fixman, D. Kamikura, T. Fournier, A. Charest, M. L. Tremblay, A. J. Wong, and M. Park. 1997. Association of the multisubstrate docking protein Gab1 with the hepatocyte growth factor receptor requires a functional Grb2 binding site involving tyrosine 1356. J. Biol. Chem. 272:20811-20819.
48. Nishimura, R., W. Li, A. Kashishian, A. Mondino, M. Zhou, J. Cooper, and J. Schlessinger. 1993. Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor. Mol. Cell. Biol. 13:6889-6896.
49. Nolle, R. T., E. J. Eck, J. Sehlessinger, S. E. Shoelson, and S. C. Harrison. 1996. Crystal structure of the PI 3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes. Nat. Struct. Biol. 3:364-374.
50. Peters, K. G., A. Coogan, D. Berry, J. Marks, J. D. Iglehart, C. D. Kontos, P. Rao, S. Sankar, and E. Trogan. 1998. Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis. Br. J. Cancer 77:51-56.
51. Ponzetto, C., A. Bardelli, F. Maina, P. Longati, G. Panayotou, R. Dhand, M Waterfleld, and P. M. Comoglio. 1993. A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor. Mol. Cell. Biol. 13:4600-4608.
52. s6k by PDK1. Science 279:707-710.
53. Puri, M. C., J. Rossant, K. Alitalo, A. Bernstein, and J. Partanen. 1995. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J. 14:5884-5891.
54. 3 interacts with SH2 domains and modulates PI 3-kinase association with tyrosine-phosphorylated proteins. Cell 83:821-830.
55. Rordorf-Nikolic, T., D. J. Van Horn, D. Chen, M. F. White, and J. M. Backer. 1995. Regulation of phosphatidylinositol 3′-kinase by tyrosyl phosphoproteins: full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit. J. Biol. Chem. 270:3662-3666.
56. Sato, T. N., Y. Tozawa, U. Deutsch, K. Wolburg-Buchholz, Y. Fujiwara, M. Gendron-Maguire, T. Gridley, H. Wolburg, W. Risau, and Y. Qin. 1995. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70-74.
57. Schlessinger, J., and A. Ullrich. 1992. Growth factor signaling by receptor tyrosine kinases. Neuron 9:383-391.
58. Skolnik, E. Y., B. Margolis, M. Mohammadi, E. Lowenstein, R. Fischer, A. Drepps, A. Ullrich, and J. Schlessinger. 1991. Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases. Cell 65:83-90.
59. Songyang, Z., S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. M. Chou, H. Hanafusa, B. Schaffhausen, and L. C. Cantley. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778.
60. Stauffer, T. P., S. Ahn, and T. Meyer. 1998. Receptor-induced transient reduction in plasma membrane phosphatidylinositol-4,5 bisphosphate concentration monitored in living cells. Curr. Biol. 8:343-346.
61. Stauffer, T. P., and T. Meyer. 1997. Compartmentalized IgE-receptor-mediated signal transduction in living cells. J. Cell Biol. 139:1447-1454.
62. Stephens, L., K. Anderson, D. Stokoe, H. Erdjument-Bromage, G. F. Painter, A. B. Holmes, P. R. J. Gaffney, C. B. Reese, F. McCormick, P. Tempst, J. Coadwell, and P. T. Hawkins. 1998. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-triphosphate-dependent activation of protein kinase B. Science 279:710-714.
63. Stokoe, D., L. R. Stephens, T. Copeland, P. R. J. Gaffney, C. B. Reese, G. F. Painter, A. B. Holmes, F. McCormick, and P. T. Hawkins. 1997. Dual role of phosphatidylinositol-3,4,5-triphosphate in the activation of protein kinase B. Science 277:567-570.
64. Stolz, L. E., W. J. Kuo, J. Longchamps, M. K. Sekhon, and J. D. York. 1998. INP51, a yeast inositol polyphosphate 5-phosphatase required for phosphatidylinositol 4,5-bisphosphate homeostasis and whose absence confers a cold-resistant phenotype. J. Biol. Chem. 273:11852-11861.
65. Suri, C., P. F. Jones, S. Patan, S. Bartunkova, P. C. Maisonpierre, S. Daris, T. N. Sato, and G. D. Yancopoulos. 1996. Requisite role for angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180.
66. Teruel, M. N., and T. Meyer. 1997. Electroporation induced formation of individual calcium entry sites in cell body and processes of adherent cells. Biophys. J. 73:1785-1796.
67. van der Geer, P., T. Hunter, and R. A. Lindberg. 1994. Receptor protein-tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol. 10:251-337.
68. Wang, J., K. R. Auger, L. Jarvis, Y. Shi, and T. M. Roberts. 1995. Direct association of Grt2 with the p85 subunit of phosphatidylinositol 3-kinase. J. Biol. Chem. 270:12774-12780.
69. Whitman, M., C. P. Downes, M. Keeler, T. Keller, and L. Cantley. 1988. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature 332:644-646.
70. Wong, A. L., Z. A. Haroon, S. Werner, M. W. Dewhirst, C. S. Greenberg, and K. G. Peters. 1997. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ. Res. 81:567-574.
71. Yokoe, H., and T. Meyer. 1996. Spatial dynamics of GFP-tagged proteins investigated by local fluorescence enhancement. Nat. Biotechnol. 14:1252-1256.
72. York, J. D., and P. W. Majerus. 1994. Nuclear phosphatidylinositols decrease during S-phase of the cell cycle in HeLa cells. J. Biol. Chem. 269:7847-7850.
73. Ziegler, S. F., T. A. Bird, J. A. Schneringer, K. A. Schooley, and P. A. Baum. 1993. Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta. Oncogene 8:663-670.